Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Therapeutics crawled date : 2023 - 01 - 09 save search
atai Life Sciences Company GABA Therapeutics Announces Positive Final Results from Phase 1 Single and Multiple Ascending Dose Trial of GRX-917
Published: 2023-01-09 (Crawled : 22:00) - biospace.com/
ATAI | $1.85 -3.14% -3.24% 940K
|
Manufacturing
|
| O: 1.65%
H: 0.54%
C: -10.81%
grx-917 sciences life trial therapeutics positive results phase 1
Vivos Therapeutics Closes $8 Million Private Placement
Published: 2023-01-09 (Crawled : 22:00) - globenewswire.com
VVOS | $2.72 2.26% 2.21% 34K
|
Health Technology
|
| O: 0.69%
H: 6.9%
C: 4.83%
therapeutics
Tenaya Therapeutics Announces TN-201 IND Clearance and Anticipated 2023 Milestones
Published: 2023-01-09 (Crawled : 21:00) - biospace.com/
TNYA | $4.31 0.47% 0.46% 410K
|
|
| O: 12.24%
H: 0.0%
C: -9.55%
tn-201 clearance therapeutics
Cogent Biosciences Announces Planned 2023 Milestones for Bezuclastinib and Emerging Portfolio of Selective and Potent Targeted Cancer Therapeutics
Published: 2023-01-09 (Crawled : 19:00) - biospace.com/
COGT | $6.71 1.51% 1.49% 1.5M
|
Health Technology
|
| O: 0.48%
H: 0.72%
C: -2.95%
bezuclastinib therapeutics cancer
Acer Therapeutics Highlights Key 2022 Achievements and Pipeline Advancements, and Provides Anticipated 2023 Milestones
Published: 2023-01-09 (Crawled : 19:00) - biospace.com/
ACER | $0.9 -3.61% 420K
|
Health Technology
|
| O: 0.0%
H: 2.15%
C: -0.72%
therapeutics
Sarepta Therapeutics Reports Preliminary* Fourth Quarter and Full-Year 2022 Net Product Revenues
Published: 2023-01-09 (Crawled : 19:00) - globenewswire.com
SRPT | $115.53 -0.88% -0.9% 640K
|
Health Technology
|
| O: 1.19%
H: 2.58%
C: 0.17%
therapeutics
Outlook Therapeutics® to Present at the Virtual Investor 2023 Companies to Watch EventLive video webcast presentation on Tuesday, January 17th at 11:00 AM ET
Published: 2023-01-09 (Crawled : 18:00) - biospace.com/
OTLK P | $8.15 -1.69% -1.72% 270K
|
Health Technology
|
| O: 0.95%
H: 0.0%
C: -0.94%
therapeutics companies presentation
4D Molecular Therapeutics Announces Updates on Clinical Pipeline and Additional Preclinical Programs
Published: 2023-01-09 (Crawled : 18:00) - biospace.com/
FDMT M | $25.29 2.06% 2.02% 630K
|
Health Technology
|
| O: 0.0%
H: 0.86%
C: -10.18%
preclinical therapeutics molecular
Celltrion and Rani Therapeutics Partner on Development of Oral Monoclonal Antibody Treatment
Published: 2023-01-09 (Crawled : 18:00) - biospace.com/
RANI | $6.86 13.39% 11.81% 200K
|
|
| O: -0.46%
H: 4.33%
C: -0.31%
treatment antibody therapeutics
Agile Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Published: 2022-08-11 (Crawled : 14:25) - ir.agiletherapeutics.com
AGRX | $0.37 0.0% 15K
|
Health Technology
|
| O: -4.91%
H: 0.0%
C: -7.38%
therapeutics financial update results
Agile Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update
Published: 2022-11-07 (Crawled : 14:25) - ir.agiletherapeutics.com
AGRX | $0.37 0.0% 15K
|
Health Technology
|
| O: -9.62%
H: 2.29%
C: -11.38%
therapeutics financial update results
Agile Therapeutics Provides Updates on 2022 Twirla Performance and 2023 Commercial Plan
Published: 2023-01-09 (Crawled : 14:25) - ir.agiletherapeutics.com
AGRX | $0.37 0.0% 15K
|
Health Technology
|
| O: 7.57%
H: 6.17%
C: -0.67%
commercial therapeutics twirla
Monte Rosa Therapeutics Outlines Progress Across Portfolio of Molecular Glue Degraders and Key Anticipated Milestones for 2023
Published: 2023-01-09 (Crawled : 14:00) - biospace.com/
GLUE | $5.84 -1.35% -1.37% 110K
|
Professional, Scientific, and T...
|
| O: 1.26%
H: 0.0%
C: -15.38%
rosa therapeutics molecular
Kintara Therapeutics to Present at the Biotech Showcase Conference on January 10, 2023
Published: 2023-01-09 (Crawled : 14:00) - biospace.com/
KTRA | $0.1204 12.95% 11.46% 7.1M
|
Distribution Services
|
| O: -2.94%
H: 7.77%
C: 0.0%
conference biotech therapeutics
Context Therapeutics and Lonza Enter Manufacturing Agreement for Bispecific Antibody Targeting Claudin 6-Positive Cancers
Published: 2023-01-09 (Crawled : 14:00) - biospace.com/
CNTX | $1.39 -1.42% -1.44% 5.7K
|
Health Technology
|
| O: 51.28%
H: 9.32%
C: -28.4%
cancer antibody therapeutics agreement cldn6
Aptevo Therapeutics Files Provisional Patent for Fifth Bispecific Antibody APVO711, Intended for the Treatment of Solid Tumors
Published: 2023-01-09 (Crawled : 14:00) - biospace.com/
APVO 4 d | $0.721 -6.36% -6.8% 230K
|
Health Technology
|
| O: 3.21%
H: 4.89%
C: 3.11%
apvo711 treatment patent antibody therapeutics tumors
ReCode Therapeutics Announces Strategic Collaboration with AskBio to Explore Single Vector Gene-Editing Platform
Published: 2023-01-09 (Crawled : 14:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.38%
H: 0.28%
C: 0.28%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.82%
H: 0.0%
C: 0.0%
collaboration therapeutics platform
Cyclo Therapeutics Announces First Patient Dosed in Phase 2b Study of Trappsol® Cyclo™ for the Treatment of Early Alzheimer’s Disease
Published: 2023-01-09 (Crawled : 14:00) - biospace.com/
CYTH | $1.19 -0.83% -0.84% 57K
|
Professional, Scientific, and T...
|
| O: 4.84%
H: 11.79%
C: -6.67%
trappsol treatment disease therapeutics alzheimer’s study phase 2b
Stoke Therapeutics Highlights Strategic Priorities and Anticipated Milestones for 2023
Published: 2023-01-09 (Crawled : 14:00) - biospace.com/
STOK | $12.08 3.69% 3.56% 1M
|
Health Technology
|
| O: 0.59%
H: 0.47%
C: -3.5%
therapeutics
Heron Therapeutics Highlights Progress in Acute Care and Oncology Care Franchises
Published: 2023-01-09 (Crawled : 14:00) - biospace.com/
HRTX M | $2.63 -2.95% -3.04% 2.3M
|
Health Technology
|
| O: 1.98%
H: 1.95%
C: 0.39%
care therapeutics
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.